We have previously reported a higher prevalence of type 2 diabetes among HNF1A S319 carriers compared to non-carriers in this population [11], which is paradoxical in the context of the current finding of S319 carriers having a low level of CRP. The gene discussed is CRP; the disease is type 2 diabetes mellitus.